Goldman Sachs Group Inc EUPRAXIA PHARMACEUTICALS INC Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
Number of Shares
39,800
Previous 34,500
15.36%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%